Physician profile
Malia Dejong
NPI 1154870624
$1,440.75
in general payments reported to CMS, 2019-2025
16 companies · $590 in 2025
The $590 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $45.21 · 2022: $154 · 2023: $329 · 2024: $322 · 2025: $590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,185 · Education: $56.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,185.17 |
| Education | $56.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $412.66 | 2022-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $260.80 | 2022-2025 | Dupixent |
| Genzyme Corporation | $133.20 | 2022-2025 | |
| Optinose US, INC. | $119.72 | 2022-2023 | |
| Jazz Pharmaceuticals INC. | $83.24 | 2024-2025 | |
| Phathom Pharmaceuticals, INC. | $59.29 | 2024-2025 | Voquezna |
| Integra Lifesciences Corporation | $54.70 | 2024-2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Astrazeneca Pharmaceuticals LP | $51.11 | 2021-2025 | Tezspire |
| Stryker Corporation | $49.86 | 2023 | Xpress Ent Dilation System |
| Smith+Nephew, INC. | $49.58 | 2025 | Halo, Tula, Ent Sinus |
| Acclarent, INC | $47.32 | 2022-2023 | Acclarent Aera |
| Baxter Healthcare | $32.42 | 2024 | Perclot |
| Ambu INC. | $24.90 | 2024 | |
| Paratek Pharmaceuticals, INC. | $24.70 | 2025 | Xhance |
| Amicus Therapeutics, INC. | $19.12 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $18.13 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Malia Dejong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.